Skip to main content

Clinical Sites

Clinic:
3333 Burnett Avenue
Cincinnati, Ohio 45229

Studies:

There are no studies at this time

Clinic:
10 Duke Medicine Circle
Durham, North Carolina 27710-1000

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.

Clinic:
2150 Pennsylvania Avenue
Washington, District of Columbia 20037

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.

Clinic:
3901 Rainbow Boulevard
Kansas City, Kansas 66160

Studies:

There are no studies at this time

Clinic:
96 Jonathan Lucas Street, Ste 301, MSC 606
Charleston, South Carolina 29464

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

Clinic:
3800 W. Chapman Ave, Suite 7400
Orange, California 92868

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

Clinic:
1120 NW 14th Street, Suite 1308
Coral Gables, Florida 33136

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

Clinic:
Medical Center Boulevard
Winston-Salem, North Carolina 27157

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

Clinic:
333 Cedar Street
New Haven, Connecticut 06510

Studies:

Closed

Designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.